Estrogen increases smooth muscle expression of α2C- adrenoceptors and cold-induced constriction of cutaneous arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 3, 2007, Pages

  Eid, A H ^a   Maiti, K ^a   Mitra, S ^a   Chotani, M A ^a   Flavahan, S ^b   Bailey, S R ^c   Thompson Torgerson, C S ^b   Flavahan, N A ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adenosine 3 ,5 cyclic monophosphate; Estrogen receptors; Rap1; Rap2; Raynaud's phenomenon

Indexed keywords

2,3 BIS(4 HYDROXYPHENYL) PROPIONITRILE; 4,4',4" (4 PROPYL [1H] PYRAZOLE 1,3,4 TRIYL) TRISPHENOL; ALPHA 2C ADRENERGIC RECEPTOR; CYCLIC AMP; ESTRADIOL; FULVESTRANT; GUANINE NUCLEOTIDE BINDING PROTEIN; PROREIN RAP2; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

ARTERY MUSCLE; ARTICLE; COLD; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ARTERIES; CELLS, CULTURED; COLD; DERMIS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; RAP GTP-BINDING PROTEINS; RAYNAUD DISEASE; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 34548440757     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00306.2007     Document Type: Article

References (50)

1. Acconcia F, Bocedi A, Ascenzi P, Marino M. Does palmitoylation target estrogen receptors to plasma membrane caveolae? IUBMB Life 55: 33-35, 2003.
2. Bailey SR, Eid AH, Mitra S, Flavahan S, Flavahan NA. Rho kinase mediates cold-induced constriction of cutaneous arteries: role of alpha2C-adrenoceptor translocation. Circ Res 94: 1367-1374, 2004.
3. Bailey SR, Mitra S, Flavahan S, Flavahan NA. Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol 289: H243-H250, 2005.
4. Barkhem T, Haldosen LA, Gustafsson JA, Nilsson S. pS2 Gene expression in HepG2 cells: complex regulation through crosstalk between the estrogen receptor alpha, an estrogen-responsive element, and the activator protein 1 response element. Mol Pharmacol 61: 1273-1283, 2002.
5. Bartelink ML, De Wit A, Wollersheim H, Theeuwes A, Thien T. Skin vascular reactivity in healthy subjects: influence of hormonal status. J Appl Physiol 74: 727-732, 1993.
6. Block JA, Sequeira W. Raynaud's phenomenon. Lancet 357: 2042-2048, 2001.
7. Bundey RA, Insel PA. Discrete intracellular signaling domains of soluble adenylyl cyclase: camps of cAMP? Sci STKE 2004: pe19, 2004.
8. Cankar K, Finderle Z, Strucl M. The role of alpha1- and alpha2-adrenoceptors in gender differences in cutaneous LD flux response to local cooling. Microvasc Res 68: 126-131, 2004.
9. Chaban VV, Lakhter AJ, Micevych P. A membrane estrogen receptor mediates intracellular calcium release in astrocytes. Endocrinology 145: 3788-3795, 2004.
10. Chan NN, MacAllister RJ, Colhoun HM, Vallance P, Hingorani AD. Changes in endothelium-dependent vasodilatation and alpha-adrenergic responses in resistance vessels during the menstrual cycle in healthy women. J Clin Endocrinol Metab 86: 2499-2504, 2001.
11. 2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am J Physiol Heart Circ Physiol 278: H1075-H1083, 2000.
12. 2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells. Am J Physiol Heart Circ Physiol 288: H69-H76, 2005.
13. 2- adrenoceptors in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 286: H59-H67, 2004.
14. Cooke JP, Creager MA, Osmundson PJ, Shepherd JT. Sex differences in control of cutaneous blood flow. Circulation 82: 1607-1615, 1990.
15. Cooper DM. Molecular and cellular requirements for the regulation of adenylate cyclases by calcium. Biochem Soc Trans 31: 912-915, 2003.
16. Das SK, Taylor JA, Korach KS, Paria BC, Dey SK, Lubahn DB. Estrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathway. Proc Natl Acad Sci USA 94: 12786-12791, 1997.
17. De Rooij J, Rehmann H, van Triest M, Cool RH, Wittinghofer A, Bos JL. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 275: 20829-20836, 2000.
18. De Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396: 474-477, 1998.
19. Ekenvall L, Lindblad LE, Norbeck O, Etzell BM. α-Adrenoceptors and cold-induced vasoconstriction in human finger skin. Am J Physiol Heart Circ Physiol 255: H1000-H1003, 1988.
20. 2-adrenoceptors. Am J Physiol Heart Circ Physiol 255: H121-H130, 1988.
21. Farhat MY, Abi-Younes S, Ramwell PW. Non-genomic effects of estrogen and the vessel wall. Biochem Pharmacol 51: 571-576, 1996.
22. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16: 70-84, 2002.
23. 2-adrenergic responses in cutaneous veins: role of receptor reserve. Am J Physiol Heart Circ Physiol 249: H950-H955, 1985.
24. Fraenkel L, Zhang Y, Chaisson CE, Evans SR, Wilson PW, Felson DT. The association of estrogen replacement therapy and the Raynaud phenomenon in postmenopausal women. Ann Intern Med 129: 208-211, 1998.
25. Freedman RR, Baer RP, Mayes MD. Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease. Circulation 92: 1448-1451, 1995.
26. Greenstein D, Jeffcote N, Ilsley D, Kester RC. The menstrual cycle and Raynaud's phenomenon. Angiology 47: 427-436, 1996.
27. Gu Q, Korach KS, Moss RL. Rapid action of 17beta-estradiol on kainate-induced currents in hippocampal neurons lacking intracellular estrogen receptors. Endocrinology 140: 660-666, 1999.
28. Hewitt SC, Deroo BJ, Korach KS. Signal transduction. A new mediator for an old hormone? Science 307: 1572-1573, 2005.
29. Hucho TB, Dina OA, Kuhn J, Levine JD. Estrogen controls PKCepsilon-dependent mechanical hyperalgesia through direct action on nociceptive neurons. Eur J Neurosci 24: 527-534, 2006.
30. 2C-adrenoceptors from golgi to plasma membrane in transfected HEK293 cells. Mol Pharmacol 60: 1195-1200, 2001.
31. Jones SE. Fulvestrant: an estrogen receptor antagonist that downregulates the estrogen receptor. Semin Oncol 30: 14-20, 2003.
32. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491-1494, 1995.
33. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM. A family of cAMP-binding proteins that directly activate Rap1. Science 282: 2275-2279, 1998.
34. 2+-controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors. J Biol Chem 279: 46497-46508, 2004.
35. Kellogg DL Jr, Liu Y, Kosiba IF, O'Donnell D. Role of nitric oxide in the vascular effects of local warming of the skin in humans. J Appl Physiol 86: 1185-1190, 1999.
36. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Forstermann U. Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 31: 582-588, 1998.
37. McLeod SJ, Shum AJ, Lee RL, Takei F, Gold MR. The Rap GTPases regulate integrin-mediated adhesion, cell spreading, actin polymerization, and Pyk2 tyrosine phosphorylation in B lymphocytes. J Biol Chem 279: 12009-12019, 2004.
38. McNeill AM, Leslie FM, Krause DN, Duckles SP. Gender difference in levels of alpha2-adrenoceptor mRNA in the rat tail artery. Eur J Pharmacol 366: 233-236, 1999.
39. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277: 1508-1510, 1997.
40. Pedram A, Razandi M, Levin ER. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20: 1996-2009, 2006.
41. 2-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol 283: R287-R295, 2002.
42. Safe S. Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62: 231-252, 2001.
43. Schaak S, Devedjian JC, Cayla C, Sender Y, Paris H. Molecular cloning, sequencing and functional study of the promoter region of the human alpha2C4-adrenergic receptor gene. Biochem J 328: 431-438, 1997.
44. Schmidt M, Evellin S, Oude Weernink PA, Dorp FV, Rehmann H, Lomasney JW, Jakobs KH. A new phospholipase-C-calcium signaling pathway mediated by cyclic AMP and Rap GTPase. Nat Cell Biol 3: 1020-1024, 2001.
45. Schwencke C, Yamamoto M, Okumura S, Toya Y, Kim SJ, Ishikawa Y. Compartmentation of cyclic adenosine 3′,5′-monophosphate signaling in caveolae. Mol Endocrinol 13: 1061-1070, 1999.
46. 2+- dependent exocytosis through both PKA and Epac2 in mouse melanotrophs from pituitary tissue slices. J Physiol 567: 799-813, 2005.
47. Taguchi Y, Koslowski M, Bodenner DL. Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA). Nucl Recept 2: 5, 2004.
48. Van Triest M, de Rooij J, Bos JL. Measurement of GTP-bound Ras-like GTPases by activation-specific probes. Methods Enzymol 333: 343-348, 2001.
49. Vanhoutte PM. Physical factors of regulation. In: Handbook of Physiology, edited by Bohr DF, Somlyo AP, and Sparks HV. Bethesda, MD: Am. Physiol. Soc., 1980, p. 443-474.
50. Wigley FM, Flavahan NA. Raynaud's phenomenon. Rheum Dis Clin North Am 22: 765-781, 1996.